US 7868169
Crystalline rosuvastatin intermediate
granted A61PA61P3/06A61P43/00
Quick answer
US patent 7868169 (Crystalline rosuvastatin intermediate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P3/06, A61P43/00